Oncology Cardiology / Cardiovascular Respiratory / COPD / Asthma Infectious Disease Gastroenterology Diabetes / Metabolic Neurology Women's Health Rheumatology Mental Health / Psychiatry Dermatology Rare Diseases Men's Health
Trial Radar • ClinicalTrials.gov • Registry-linked

Trial Radar

2231 clinical trials with phase, status, specialty and registry links, summarised for rapid clinical review.

2231 recruiting AI clinical summaries
Explore Trial Collections Follow research updates
All Phases Phase I Phase II Phase III Phase IV
Therapeutic Area: All Cardiology / Cardiovascular Dermatology Diabetes / Metabolic Gastroenterology Haematology Infectious Disease Men's Health Mental Health / Psychiatry Nephrology Neurology Oncology Rare Diseases
🔬
Trial Radar

Clinical Trial Intelligence

● Recruiting Phase III Rheumatology
A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn’s Disease
A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn’s Disease is Recruiting • Phase III • Rheumatology • NCT05509777. Study participants will be…
27 Mar 2026 NCT05509777
● Recruiting Phase II Rheumatology
A Study to Investigate the Efficacy and Safety of SAR442970 in Adult Participants With Ulcerative Colitis
A Study to Investigate the Efficacy and Safety of SAR442970 in Adult Participants With Ulcerative Colitis is Recruiting • Phase II • Rheumatology •…
27 Mar 2026 NCT06975722
● Recruiting Phase II Rheumatology
A Study to Investigate Efficacy and Safety of SAR442970 in Patients With Crohn’s Disease
A Study to Investigate Efficacy and Safety of SAR442970 in Patients With Crohn’s Disease is Recruiting • Phase II • Rheumatology • NCT06958536. This…
27 Mar 2026 NCT06958536
● Recruiting Phase III Rheumatology
A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn’s Disease (SHINE-ON)
A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn’s Disease (SHINE-ON) is Recruiting • Phase III…
27 Mar 2026 NCT04844606
● Recruiting Phase III Oncology
Pembrolizumab With or Without Maintenance Sacituzumab Tirumotecan (Sac-TMT; MK-2870) in Metastatic Squamous Non-small Cell Lung Cancer (NSCLC) [MK-2870-023]
Pembrolizumab With or Without Maintenance Sacituzumab Tirumotecan (Sac-TMT; MK-2870) in Metastatic Squamous Non-small Cell Lung Cancer (NSCLC) [MK-2870-023] is Recruiting • Phase III •…
27 Mar 2026 NCT06422143
● Recruiting Phase III Oncology
A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)
A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%.…
27 Mar 2026 NCT07361510
● Recruiting Respiratory / COPD / Asthma
Evaluation of High Dose Prednisolone Pharmacokinetics in the Acute and Chronic Setting
Evaluation of High Dose Prednisolone Pharmacokinetics in the Acute and Chronic Setting is Recruiting • Phase not applicable • Respiratory / COPD / Asthma…
27 Mar 2026 NCT05012033
● Recruiting Phase III Respiratory / COPD / Asthma
A Study to Test Whether Nerandomilast Helps People With Lungfibrosis Related to Rheumatic Diseases
A Study to Test Whether Nerandomilast Helps People With Lungfibrosis Related to Rheumatic Diseases is Recruiting • Phase III • Respiratory / COPD /…
27 Mar 2026 NCT06806592
● Recruiting Phase III Respiratory / COPD / Asthma
A Study of mRNA-1018-H5 Pandemic Influenza Vaccine in Healthy Adults
A Study of mRNA-1018-H5 Pandemic Influenza Vaccine in Healthy Adults is Recruiting • Phase III • Respiratory / COPD / Asthma • NCT07496450. The…
27 Mar 2026 NCT07496450
● Recruiting Respiratory / COPD / Asthma
A Study to Evaluate Patient-Reported Satisfaction, Effectiveness, and Safety of Atezolizumab in Participants Treated in Routine Clinical Practice
A Study to Evaluate Patient-Reported Satisfaction, Effectiveness, and Safety of Atezolizumab in Participants Treated in Routine Clinical Practice is Recruiting • Phase not applicable…
27 Mar 2026 NCT07284121
● Recruiting Phase III Oncology
A Clinical Study of Sotatercept (MK-7962) in People With Pulmonary Arterial Hypertension (MK-7962-038)
A Clinical Study of Sotatercept (MK-7962) in People With Pulmonary Arterial Hypertension (MK-7962-038) is Recruiting • Phase III • Oncology • NCT07218029. Researchers are…
27 Mar 2026 NCT07218029
● Recruiting Phase III Respiratory / COPD / Asthma
A Study of Baricitinib (LY3009104) to Preserve Beta Cell Function in Children and Adults Newly Diagnosed With Type 1 Diabetes (BARICADE-PRESERVE)
A Study of Baricitinib (LY3009104) to Preserve Beta Cell Function in Children and Adults Newly Diagnosed With Type 1 Diabetes (BARICADE-PRESERVE) is Recruiting •…
27 Mar 2026 NCT07222332
● Recruiting Phase III Cardiology / Cardiovascular
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity is Recruiting • Phase III…
27 Mar 2026 NCT07037433
● Recruiting Cardiology / Cardiovascular
Coronary Flow During Rapid Heart Rates
Coronary Flow During Rapid Heart Rates is Recruiting • Phase not applicable • Cardiology / Cardiovascular • NCT05841199. The goal of this observational study…
27 Mar 2026 NCT05841199
● Recruiting Phase I Oncology
A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies is Recruiting • Phase I • Oncology • NCT05131022. This is a first-in-human Phase…
27 Mar 2026 NCT05131022
● Recruiting Phase III Cardiology / Cardiovascular
MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)
MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM) is Recruiting • Phase III • Cardiology / Cardiovascular…
27 Mar 2026 NCT06128629
● Recruiting Phase II Cardiology / Cardiovascular
Safety and Efficacy of Tarperprumig in Adult Participants With Anti-Neutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis
Safety and Efficacy of Tarperprumig in Adult Participants With Anti-Neutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis is Recruiting • Phase II • Cardiology / Cardiovascular •…
27 Mar 2026 NCT07160608
● Recruiting Cardiology / Cardiovascular
Product Surveillance Registry
Product Surveillance Registry is Recruiting • Phase not applicable • Cardiology / Cardiovascular • NCT01524276. The purpose of the Registry is to provide continuing…
27 Mar 2026 NCT01524276
● Recruiting Phase III Cardiology / Cardiovascular
A Study to Learn About the Study Medicine Elranatamab Alone and With Daratumumab in People With Multiple Myeloma Who Have Received Other Treatments
A Study to Learn About the Study Medicine Elranatamab Alone and With Daratumumab in People With Multiple Myeloma Who Have Received Other Treatments is…
27 Mar 2026 NCT05020236
● Recruiting Phase III Oncology
A Study to Compare Sacituzumab Tirumotecan (MK-2870) Monotherapy Versus Treatment of Physician’s Choice as Second-line Treatment for Participants With Recurrent or Metastatic Cervical Cancer (MK-2870-020/TroFuse-020/Gog-3101/ENGOT-cx20)
A Study to Compare Sacituzumab Tirumotecan (MK-2870) Monotherapy Versus Treatment of Physician’s Choice as Second-line Treatment for Participants With Recurrent or Metastatic Cervical Cancer…
27 Mar 2026 NCT06459180
● Recruiting Phase I Oncology
A Study of Patritumab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01C/LIGHTBEAM-U01)
A Study of Patritumab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01C/LIGHTBEAM-U01) is Recruiting • Phase I • Oncology • NCT06941272.…
27 Mar 2026 NCT06941272
● Recruiting Phase II Oncology
Study BT8009-230 in Participants With Locally Advanced or Metastatic Urothelial Cancer (Duravelo-2)
Study BT8009-230 in Participants With Locally Advanced or Metastatic Urothelial Cancer (Duravelo-2) is Recruiting • Phase II • Oncology • NCT06225596. This is a…
27 Mar 2026 NCT06225596
● Recruiting Oncology
Population Based Germline Testing for Early Detection and Prevention of Cancer
Population Based Germline Testing for Early Detection and Prevention of Cancer is Recruiting • Phase not applicable • Oncology • NCT07498829. PROTECT-C is a…
27 Mar 2026 NCT07498829
● Recruiting Phase II Oncology
A Study of Zilovertamab Vedotin (MK-2140) in Combination With Standard of Care in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (rrDLBCL) (MK-2140-003)
A Study of Zilovertamab Vedotin (MK-2140) in Combination With Standard of Care in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (rrDLBCL) (MK-2140-003)…
27 Mar 2026 NCT05139017
● Recruiting Phase III Oncology
A Study Comparing Anitocabtagene Autoleucel to Standard of Care Therapy in Participants With Relapsed/ Refractory Multiple Myeloma
A Study Comparing Anitocabtagene Autoleucel to Standard of Care Therapy in Participants With Relapsed/ Refractory Multiple Myeloma is Recruiting • Phase III • Oncology…
27 Mar 2026 NCT06413498
● Recruiting Phase III Respiratory / COPD / Asthma
A Multicentre, Randomised, Double-blind, Parallel Group, Placebo-controlled, Time-to-first Asthma Exacerbation Phase III Efficacy and Safety Study of Benralizumab in Paediatric Patients With Severe Eosinophilic Asthma (DOMINICA)
A Multicentre, Randomised, Double-blind, Parallel Group, Placebo-controlled, Time-to-first Asthma Exacerbation Phase III Efficacy and Safety Study of Benralizumab in Paediatric Patients With Severe Eosinophilic…
25 Mar 2026 NCT05692180
● Recruiting Phase III Respiratory / COPD / Asthma
A Study Assessing the Effect of Dupilumab on Inducing Clinical Remission in Asthma
A Study Assessing the Effect of Dupilumab on Inducing Clinical Remission in Asthma is Recruiting • Phase III • Respiratory / COPD / Asthma…
25 Mar 2026 NCT07309614
● Recruiting Phase II Respiratory / COPD / Asthma
Study of Lunsekimig (SAR443765) Compared With Placebo in Adults With High-risk Asthma
Study of Lunsekimig (SAR443765) Compared With Placebo in Adults With High-risk Asthma is Recruiting • Phase II • Respiratory / COPD / Asthma •…
25 Mar 2026 NCT06676319
● Recruiting Phase I Respiratory / COPD / Asthma
RIG 101 Trial in Healthy Adults and Adults With Asthma
RIG 101 Trial in Healthy Adults and Adults With Asthma is Recruiting • Phase I • Respiratory / COPD / Asthma • NCT07488897. Nested…
25 Mar 2026 NCT07488897
● Recruiting Phase IV Respiratory / COPD / Asthma
Study Assessing the Long-term Effect of Dupilumab on Prevention of Lung Function Decline in Adult Patients With Uncontrolled Moderate to Severe Asthma
Study Assessing the Long-term Effect of Dupilumab on Prevention of Lung Function Decline in Adult Patients With Uncontrolled Moderate to Severe Asthma is Recruiting…
25 Mar 2026 NCT05097287
● Recruiting Phase III Respiratory / COPD / Asthma
Efficacy and Safety of Subcutaneous Dupilumab in Participants With Asthma/Asthmatic Wheeze Aged 2 to
Efficacy and Safety of Subcutaneous Dupilumab in Participants With Asthma/Asthmatic Wheeze Aged 2 to is Recruiting • Phase III • Respiratory / COPD /…
25 Mar 2026 NCT06191315
● Recruiting Phase III Respiratory / COPD / Asthma
Randomised Clinical Trial to Investigate Efficacy and Safety of Benralizumab 30 mg SC as an add-on Therapy in Uncontrolled Eosinophilic Asthma Patients Treated With Medium-dose ICS-LABA Compared to Conventional Escalation to High-dose ICS-LABA Treatment
Randomised Clinical Trial to Investigate Efficacy and Safety of Benralizumab 30 mg SC as an add-on Therapy in Uncontrolled Eosinophilic Asthma Patients Treated With…
25 Mar 2026 NCT06750289
● Recruiting Phase IV Respiratory / COPD / Asthma
Molecular Signatures Associated With Response to ICS Treatment in Patients With COPD Stratified by Eosinophil Levels
Molecular Signatures Associated With Response to ICS Treatment in Patients With COPD Stratified by Eosinophil Levels is Recruiting • Phase IV • Respiratory /…
25 Mar 2026 NCT06334575
● Recruiting Phase III Respiratory / COPD / Asthma
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an…
25 Mar 2026 NCT07190209
● Recruiting Phase II Respiratory / COPD / Asthma
A Study to Evaluate Solrikitug in Participants With COPD (ZION)
A Study to Evaluate Solrikitug in Participants With COPD (ZION) is Recruiting • Phase II • Respiratory / COPD / Asthma • NCT06496620. A…
25 Mar 2026 NCT06496620
● Recruiting Phase III Respiratory / COPD / Asthma
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an…
25 Mar 2026 NCT07190222
● Recruiting Phase IV Oncology
A Study to Investigate the Effect of Budesonide/Glycopyrronium/Formoterol Fumarate Metered Dose Inhaler (BGF MDI) Compared With Placebo MDI on Heart and Lung Function in Participants With Chronic Obstructive Pulmonary Disease (COPD) and Hyperinflation
A Study to Investigate the Effect of Budesonide/Glycopyrronium/Formoterol Fumarate Metered Dose Inhaler (BGF MDI) Compared With Placebo MDI on Heart and Lung Function in…
25 Mar 2026 NCT07073950
● Recruiting Phase II Respiratory / COPD / Asthma
A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease is Recruiting • Phase II…
25 Mar 2026 NCT07082738
● Recruiting Respiratory / COPD / Asthma
An Evaluation of the AeriSeal System for CONVERTing Collateral Ventilation Status in Patients With Severe Emphysema
An Evaluation of the AeriSeal System for CONVERTing Collateral Ventilation Status in Patients With Severe Emphysema is Recruiting • Phase not applicable • Respiratory…
25 Mar 2026 NCT06035120
● Recruiting Cardiology / Cardiovascular
PulseSelect™ PFA Global Registry
PulseSelect™ PFA Global Registry is Recruiting • Phase not applicable • Cardiology / Cardiovascular • NCT06393920. The PulseSelect™ PFA Global Registry is a prospective,…
25 Mar 2026 NCT06393920
● Recruiting Cardiology / Cardiovascular
Rate or Rhythm Control in CRT: the RHYTHMIC Study
Rate or Rhythm Control in CRT: the RHYTHMIC Study is Recruiting • Phase not applicable • Cardiology / Cardiovascular • NCT04664686. 70 patients with…
25 Mar 2026 NCT04664686
● Recruiting Phase III Cardiology / Cardiovascular
Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG
Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG is Recruiting • Phase III • Cardiology / Cardiovascular • NCT04045665. The primary objective of this…
25 Mar 2026 NCT04045665
● Recruiting Cardiology / Cardiovascular
The Fourth Left Atrial Appendage Occlusion Study
The Fourth Left Atrial Appendage Occlusion Study is Recruiting • Phase not applicable • Cardiology / Cardiovascular • NCT05963698. LAAOS-4 aims to determine if…
25 Mar 2026 NCT05963698
● Recruiting Cardiology / Cardiovascular
Early Closure of Left Atrial Appendage for Patients With Atrial Fibrillation and Ischemic Stroke Despite Anticoagulation Therapy
Early Closure of Left Atrial Appendage for Patients With Atrial Fibrillation and Ischemic Stroke Despite Anticoagulation Therapy is Recruiting • Phase not applicable •…
25 Mar 2026 NCT05976685
● Recruiting Phase II Cardiology / Cardiovascular
A Study to Investigate the Efficacy, Safety, Tolerability and Pharmacokinetics of PKN605 in Participants With Atrial Fibrillation
A Study to Investigate the Efficacy, Safety, Tolerability and Pharmacokinetics of PKN605 in Participants With Atrial Fibrillation is Recruiting • Phase II • Cardiology…
25 Mar 2026 NCT07217067
● Recruiting Phase III Cardiology / Cardiovascular
Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI…
25 Mar 2026 NCT05712200
● Recruiting Cardiology / Cardiovascular
A Registry on the FARAVIEW Technology of the OPAL HDx Mapping System When Used With the FARAWAVE NAV Ablation Catheter in the Treatment of Atrial Fibrillation
A Registry on the FARAVIEW Technology of the OPAL HDx Mapping System When Used With the FARAWAVE NAV Ablation Catheter in the Treatment of…
25 Mar 2026 NCT06808217
● Recruiting Cardiology / Cardiovascular
The Use of Advanced Imaging in HFpEF
The Use of Advanced Imaging in HFpEF is Recruiting • Phase not applicable • Cardiology / Cardiovascular • NCT06905405. Heart failure with preserved ejection…
25 Mar 2026 NCT06905405
● Recruiting Phase II Cardiology / Cardiovascular
A Study to Learn About the Study Medicine Called PF-07328948 in Adults With Heart Failure (BRANCH-HF)
A Study to Learn About the Study Medicine Called PF-07328948 in Adults With Heart Failure (BRANCH-HF) is Recruiting • Phase II • Cardiology /…
25 Mar 2026 NCT06991257
● Recruiting Cardiology / Cardiovascular
Development of Novel Physiological CMR Methods in Health and Disease
Development of Novel Physiological CMR Methods in Health and Disease is Recruiting • Phase not applicable • Cardiology / Cardiovascular • NCT03854071. Physiological cardiovascular…
25 Mar 2026 NCT03854071